These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12654063)

  • 1. Biochemical and molecular characterization of mutant hexosaminidase A in a Turkish family.
    Sinici I; Ozkara HA; Topçu M; Ciliv G
    Pediatr Int; 2003 Feb; 45(1):16-22. PubMed ID: 12654063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new point mutation (G412 to A) at the last nucleotide of exon 3 of hexosaminidase alpha-subunit gene affects splicing.
    Ozkara HA; Sandhoff K
    Brain Dev; 2003 Apr; 25(3):203-6. PubMed ID: 12689701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At least six different mutations in HEXA gene cause Tay-Sachs disease among the Turkish population.
    Ozkara HA; Navon R
    Mol Genet Metab; 1998 Nov; 65(3):250-3. PubMed ID: 9851891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
    Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
    J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM2 gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A.
    Peleg L; Meltzer F; Karpati M; Goldman B
    Biochem Mol Med; 1995 Apr; 54(2):126-32. PubMed ID: 8581357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
    Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
    J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.
    Ozkara HA; Sandhoff K
    Brain Dev; 2003 Apr; 25(3):191-4. PubMed ID: 12689698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene.
    Harmon DL; Gardner-Medwin D; Stirling JL
    J Med Genet; 1993 Feb; 30(2):123-8. PubMed ID: 8445615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the severity of the small inframe deletion mutation in the alpha-subunit of beta-hexosaminidase A found in the Turkish population by reproducing it in the more stable beta-subunit.
    Sinici I; Tropak MB; Mahuran DJ; Ozkara HA
    J Inherit Metab Dis; 2004; 27(6):747-56. PubMed ID: 15505380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
    Brown CA; Mahuran DJ
    J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of heat labile hexosaminidase B among Jews and Arabs.
    Narkis G; Adam A; Jaber L; Pennybacker M; Proia RL; Navon R
    Hum Mutat; 1997; 10(6):424-9. PubMed ID: 9401004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
    Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
    Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
    Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
    Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
    Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
    Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double mutation in exon 6 of the beta-hexosaminidase alpha subunit in a patient with the B1 variant of Tay-Sachs disease.
    Ainsworth PJ; Coulter-Mackie MB
    Am J Hum Genet; 1992 Oct; 51(4):802-9. PubMed ID: 1415222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
    Bayleran J; Hechtman P; Kolodny E; Kaback M
    Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.